News Headlines Article

Summary Box: Drugmakers post higher Q2 results
San Francisco Chronicle

HEALTHY SIGNS: Three of the Top 20 drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — all post better second-quarter profit as their sales increase.

UNDER PRESSURE: Revenue across the industry is being squeezed by the U.S. health care overhaul, the European economic crisis, shifting currency exchange rates and generic competition. The impact of the first two likely will increase later this year and next year.